Dow Up 0.11% Nasdaq Up 0.50%

More On TSRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Trius Therapeutics, Inc. (TSRX)

-NGM
13.63 0.00(0.00%) Sep 11, 4:00PM EDT
Prev Close:13.63
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:14.33
Beta:1.4
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:4.41 - 14.17
Volume:0
Avg Vol (3m):1,634,750
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :N/A
Quarterly EPS Est (Sep-13) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trius Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics for serious infections. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback